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MaOBJECTIVES The aim of this study was to evaluate the appropriateness of percutaneous coronary intervention (PCI) in
Japan and clarify the association between trends of pre-procedural noninvasive testing and changes in appropriateness
ratings.
BACKGROUND Although PCI appropriateness criteria are widely used for quality-of-care improvement, they have not
been validated internationally. Furthermore, the correlation of appropriateness ratings with implementation of newly
developed noninvasive testing is unclear.
METHODS We assigned an appropriateness rating to 11,258 consecutive PCIs registered in the Japanese Cardiovascular
Database according to appropriateness use criteria developed in 2009 (AUC/2009) and the 2012 revised version
(AUC/2012). Trends of pre-procedural noninvasive testing and appropriateness ratings were plotted; logistic regression
was performed to identify inappropriate PCI predictors.
RESULTS In nonacute settings, 15% of PCIs were rated inappropriate under AUC/2009, and this percent increased to
30.7% under AUC/2012 criteria. This was mostly because of the focused update of AUC, in which the patients were newly
classiﬁed as inappropriate if they lacked proximal left anterior descending lesions and did not undergo pre-procedural
noninvasive testing. However, these cases were simply not rated under AUC/2009. The amount of inappropriate PCIs
increased over 5 years, proportional to the increase in coronary computed tomography angiography use. Use of coronary
computed tomography angiography was independently associated with inappropriate PCIs (odds ratio: 1.33; p ¼ 0.027).
CONCLUSIONS In a multicenter, Japanese PCI registry, approximately one-sixth of nonacute PCIs were rated as
inappropriate under AUC/2009, increasing to approximately one-third under the revised AUC/2012. This signiﬁcant gap
may reﬂect a needed shift in appropriateness recognition of methods for noninvasive pre-procedural evaluation of
coronary artery disease. (J Am Coll Cardiol Intv 2014;7:1000–9) © 2014 by the American College of Cardiology
Foundation.T he advent of percutaneous coronary inter-vention (PCI) has signiﬁcantly changed thetreatment strategy for patients with coronary
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AB BR EV I A T I O N S
AND ACRONYM S
AUC = appropriateness use
criteria
CABG = coronary artery bypass
grafting
CAD = coronary artery disease
CTA = computed tomography
angiography
CT = computed tomography
FFR = fractional ﬂow reserve
JCD = Japan Cardiovascular
Database
PCI = percutaneous coronary
intervention
PLAD = proximal left anterior
descending artery
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1001with acute coronary syndrome (1), its survival beneﬁt
has not been clearly established for patients with sta-
ble CAD (2). Because the patients who undergo PCI
are exposed to the risks of periprocedural complica-
tions such as bleeding or procedure-related myocar-
dial infarction, the appropriate indications of PCI
are of signiﬁcant importance.
To promote the appropriate and judicious imple-
mentation of PCI, the American College of Cardiology
Foundation and 6 other societies published joint
appropriateness use criteria (AUC) for PCI in
2009 (AUC/2009) (3). These AUC have been applied
to real-world clinical practice along with various
registry data, and studies have demonstrated a
strong possibility of PCI overuse in real-world prac-
tice in Western countries (4–6). However, reports on
AUC application to patients outside of North America
are sparse.SEE PAGE 1010In Japan, the number of PCI procedures has been
increasing. More than 200,000 procedures in >800
hospitals were performed in 2012; this number is
disproportionately large compared with the number
of coronary artery bypass grafting (CABG) procedures.
The number of PCI procedures is estimated to be >14
times greater than CABG procedures (7). Conse-
quently, whereas the proportion of elective PCIs
accounts for < 40% in the United States, as many as
three-fourths of PCIs are performed in nonacute set-
tings in Japan (7,8), and a greater number of patients
with multivessel diseases are treated with PCI in
Japan than in the United States (9). Furthermore, the
pre-procedural evaluation is also quite different
between the 2 countries: the performance of coronary
CT angiography (CTA) is increasing remarkably in
Japan, whereas the stress testing remains the main
modality in the United States. These unique charac-
teristics in Japan underscore the need for a proper
evaluation of PCI appropriateness.
The purpose of our study was to evaluate the
appropriateness of PCI indications in Japan on the
basis of U.S. criteria and to compare the rate and
characteristics of inappropriate PCIs between both
countries. At present, 2 versions of AUC have been
published in the United States. The original AUC/
2009 was updated in 2012 (AUC/2012), emphasizing
the importance of performing noninvasive stress
testing before elective PCIs (10). The use of coronary
CTA as a pre-procedural test is increasing in Japan
and may have signiﬁcantly altered appropriateness
ratings. Although the risk of adverse cardiovascular
events could be stratiﬁed by the extent of anatomic
lesions on the basis of coronary CTA, computedtomography (CT)–based PCIs are rarely
recognized as appropriate indications under
current AUC. Therefore, in addition to
reviewing the overall rating of PCI appropri-
ateness, we sought to clarify its association
with the trend in performing various nonin-
vasive diagnostic tests.
METHODS
DATA SOURCE. The Japan Cardiovascular
Database (JCD) is an ongoing, prospective
multicenter registry designed to collect clin-
ical background and outcome data on
consecutive PCI patients (11). In this registry,
16 teaching hospitals within the metropolitan
Tokyo area participated and registered all PCI
procedures performed during the study period,
including failure cases, using an Internet-based
interface. Approximately 200 variables were
collected for each patient; clinical variables and in-
hospital outcomes for JCD were deﬁned in accor-
dance with the National Cardiovascular Data Registry
version 4.1. This registry, sponsored by the American
College of Cardiology (12,13), is the largest national
clinical registry program for diagnostic cardiac cath-
eterization and PCI, with >1,500 centers currently
participating across the United States. Additionally,
in the JCD-PCI registry, the subgroup of patients who
underwent an intracoronary infusion of acetylcholine
to induce coronary vasospasm was also registered
because vasospastic angina accounts for a signiﬁcant
portion of patients with CAD and acute coronary
syndromes in Japan (14). Clinical research co-
ordinators speciﬁcally trained in registering PCI pro-
cedures conﬁrmed the proper registration of each
patient. In addition, data reported on the Internet-
based system were checked, and investigators
visited each hospital quarterly to audit the database
for completeness and consistency.
STUDY POPULATION. A total of 11,258 consecutive
patients who underwent PCI procedures between
September 2008 and March 2013 for acute and non-
acute indications were registered in the database. A
total of 1,208 patients were excluded because they
underwent serial PCIs during the same hospitaliza-
tion, there were insufﬁcient baseline data, or they
only underwent the acetylcholine challenge test. The
remaining 10,050 patients were included in our study
(Figure 1).
DEVELOPMENT OF AUC/2009 AND ITS RATING
ASSIGNMENTS. AUC/2009 was developed by a colla-
boration of 6 American professional organizations
FIGURE 1 Study Cohort Creation
Patients registered in JCD-PCI Registry were divided into 2 groups (nonacute and acute indications). Each group was rated under AUC/2009
and AUC/2012. A ¼ appropriate; Ach ¼ acetylcholine; AUC ¼ appropriateness use criteria; I ¼ inappropriate; JCD-PCI ¼ Japan Cardiovascular
Database–Percutaneous Coronary Intervention; LVEF ¼ left ventricular ejection fraction; U ¼ uncertain.
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1002(the American College of Cardiology Foundation, the
Society for Cardiovascular Angiography and Inter-
vention, the Society of Thoracic Surgeons, the Amer-
ican Association for Thoracic Surgery, the American
Heart Association, and theAmerican Society of Nuclear
Radiology) in 2009. The methodology to develop the
AUC for coronary revascularization was previously
described (3).
We used an algorithm to map PCIs in the JCD-PCI
registry to AUC/2009 and rate the procedures as
appropriate, uncertain, or inappropriate. This algo-
rithm, which was validated in a previous study (6),
enabled the mapping to be performed in an efﬁcient
manner. All the deﬁnitions in our study were iden-
tical to those in AUC/2009. We optimized our
mapping algorithm to maximize the use of existing
data and minimize the inﬂuence of missing data.
For example, certain nonacute indications can be
assigned the appropriateness rating independent of
noninvasive risk results (e.g., 3-vessel CAD with
abnormal left ventricular systolic function). In these
scenarios, an appropriateness classiﬁcation could beprovided even when noninvasive risk testing was not
performed or results were not available.
Among the 10,050 patients, a rating could not be
determined for 2,968 nonacute and 1,105 acute PCIs,
leaving a total of 1,982 nonacute and 3,995 acute PCIs
that could be rated (Figure 1). Among the acute in-
dications, unstable angina without high-risk features
was the main cause of rating failure. In the nonacute
settings, mapping failure was mainly due to one of
the following: no previous stress test performed,
staged PCI, previous stress test with no ischemia or
equivocal result, previous evaluation of left ventric-
ular systolic function, and matched to indications
that were not rated.
REVISED AUC/2012 AND ITS RATING ASSIGNMENTS.
AUC/2009 was updated in 2012 (AUC/2012) (10). In the
revised AUC/2012 version, unstable angina without
high-risk features, which was an excluded clinical
scenario in AUC/2009, was successfully mapped and
divided into 2 indications according to the Throm-
bolysis In Myocardial Infarction score. In AUC/2009,
TABLE 1 Baseline Characteristics of Acute and Nonacute PCIs
Total
(N ¼ 10,050)
Acute
(n ¼ 5100)
Nonacute
(n ¼ 4950)
Demographics
Male 7,978 (79.4) 3,972 (77.9) 4,006 (80.9)
Age, yrs 67.9  10.9 67.5  11.8 68.2  9.7
Clinical factors
Hypertension 7,462 (74.3) 3,588 (70.4) 3,874 (78.3)
Hypercholesterolemia 6,681 (66.6) 3,109 (61.1) 3,572 (72.2)
Diabetes mellitus 4,229 (42.1) 1,901 (37.4) 2,328 (47.0)
Current and past smoking 3,517 (35.1) 2,022 (39.8) 1,495 (30.3)
History of MI 2,501 (24.9) 799 (15.7) 1,702 (34.4)
Previous PCI 3,613 (36.0) 990 (19.4) 2,623 (53.0)
Previous CABG 532 (5.3) 195 (3.8) 337 (6.8)
Hemodialysis 430 (4.3) 181 (3.6) 249 (5.0)
Cerebrovascular disease 909 (9.1) 454 (8.9) 455 (9.2)
Peripheral arterial disease 817 (8.1) 292 (5.7) 525 (10.6)
Chronic lung disease 309 (3.1) 153 (3.0) 156 (3.2)
Values are n (%) or mean  SD.
CABG ¼ coronary artery bypass grafting; MI ¼ myocardial infarction; PCI ¼ percutaneous
coronary intervention.
TABLE 2 All the Clinical Scenarios in the Acute Setting
AUC/2009
Indication No. Indication n (%)
Appropriate PCI
1 STEMI, #12 h from onset of symptoms
Revascularization of the culprit artery
1,397 (35.0)
9 UA/NSTEMI and high-risk features of short-term
risk if death or nonfatal MI
1,361 (34.1)
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1003the clinical scenario of an asymptomatic patient
without previous bypass surgery and with 1- or
2-vessel disease not involving the proximal left ante-
rior descending artery (PLAD) who underwent no
noninvasive testing was not evaluated because it was
thought to be uncommon. However, in the revised
AUC/2012, this clinical scenario was determined to be
inappropriate. Accordingly, successfully mapped
procedures increased, and 2,429 nonacute and 5,100
acute PCIs were rated (Figure 1).
STATISTICAL ANALYSIS. The proportion of PCIs
classiﬁed as appropriate, uncertain, or inappropriate
was determined, after stratiﬁcation by acute versus
nonacute indications on the basis of AUC/2009 and
AUC/2012. Baseline characteristics and clinical vari-
ables of patients were compared by appropriateness
categories. Differences were evaluated using the
chi-square or Fisher exact test for categorical vari-
ables and the Student unpaired t test for continuous
variables. Cochran-Armitage analysis was used to
evaluate the trends of the proportion of inappropriate
PCIs and of the implementation of various tests.
Multivariate logistic regression analysis was per-
formed to examine the relationship between the
implementation of coronary CTA and inappropriate
PCI, adjusting for potential confounders. The cova-
riates included in the model were symptomatic status
(symptomatic vs. asymptomatic), extent of ischemic
burden (low risk vs. intermediate or high risk), anti-
anginal medication (optimal vs. suboptimal medica-
tion), angiographic characteristics (left main trunk,
triple-vessel disease, chronic total occlusion, or
PLAD), and the time period when the PCI was per-
formed (divided into 8 categories: September 2008 to
June 2009, July 2009 to December 2009, January 2010
to June 2010, July 2010 to December 2010, January
2011 to June 2011, July 2011 to December 2011, January
2012 to June 2012, and July 2012 to March 2013). Data
were analyzed using SPSS, version 20 (SPSS Inc.,
Chicago, Illinois). All p values were 2-sided, and sig-
niﬁcance was deﬁned as p < 0.05 for all analyses.Revascularization of the presumed culprit artery
11 Patients with acute myocardial infarction
(STEMI or NSTEMI)
Evidence of cardiogenic shock
Revascularization of $1 coronary arteries
755 (18.9)
2 STEMI, onset of symptoms within the previous 12–24 h
Severe HF, persistent ischemic symptoms,
or hemodynamic or electrical instability present
336 (8.4)
Inappropriate PCI
3 STEMI, >12 h from symptom onset
Asymptomatic; no hemodynamic instability
and no electrical instability
146 (3.7)
AUC ¼ appropriateness use criteria; HF ¼ heart failure; MI ¼ myocardial infarction; NSTEMI ¼ non–ST-segment
elevation myocardial infarction; PCI ¼ percutaneous coronary intervention; STEMI ¼ ST-segment elevation
myocardial infarction; UA ¼ unstable angina.RESULTS
PATIENT CHARACTERISTICS. Table 1 summarizes
the clinical characteristics of patients who underwent
PCIs in acute and nonacute settings. The mean age
was 67.9  10.9 years; 79.4% were male. Coronary risk
factors, including a history of myocardial infarction
and PCI, hypertension, hypercholesterolemia, and
diabetes mellitus, were common; however, the prev-
alence of a history of CABG was lower than that in
previous reports (4).ACUTE INDICATIONS. Among the patients with acute
indications for PCI, ST-segment elevation myocardial
infarction was found in 49.3%, whereas cardiogenic
shock was found in 16.9%. All clinical indications for
appropriate and inappropriate PCIs in the acute
settings are outlined in Table 2. Overall, most acute
indications (96.3%) were categorized as appropriate
under AUC/2009 (Figure 2, Online Table 1), whereas
all inappropriate procedures were categorized as
hemodynamic and electrically stable patients, with
FIGURE 2 Appropriate Ratings Under Each Criterion
Appropriate ratings under each criterion in acute (A) settings and nonacute (B) settings. AUC ¼ appropriateness use criteria.
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1004PCI performed >12 h after symptom onset after
ST-segment elevation myocardial infarction.
On the basis of AUC/2012, almost all cases of
unstable angina without high-risk features (997
[90.2%]) were classiﬁed as uncertain, whereas 108
(9.8%) were considered appropriate. Overall, nearly
80% of acute procedures were categorized as appro-
priate (3,957 [77.6%]), whereas 997 (19.5%) were
categorized uncertain and 146 (2.9%) wereTABLE 3 Key Variables in Classifying Appropriateness for Nonacute
Total
(N ¼ 1,982)
App
(n
Angina
No symptoms 555 (32.2) 17
CCS angina class
I 377 (19.0) 6
II 750 (37.8) 188
III 239 (12.1) 214
IV 38 (1.9) 30
Unknown 23 (1.2) 2
Noninvasive ischemia evaluation
Low risk 228 (11.5) 19
Intermediate risk 742 (37.4) 228
High risk 195 (9.8) 156
Maximal antianginal medications 117 (5.9) 70
Angiographic characteristics
Left main trunk 111 (5.6) 109
3VD without left main trunk 345 (17.4) 290
CTO without other coronary stenosis 77 (3.9) 1
Presence of proximal LAD stenosis 508 (25.6) 316
Values are n (%).
CCS ¼ Canadian Cardiovascular Society; CTO ¼ chronic total occlusion; LAD ¼ left antinappropriate (Figure 2, Online Table 1). All clinical
indications for acute PCIs assessed by AUC/2012 are
shown in Online Table 2.
NONACUTE INDICATIONS. In nonacute settings,
35.1% of PCIs were classiﬁed as appropriate, 49.9% as
uncertain, and 15.0% as inappropriate under AUC/
2009 (Figure 2, Online Table 1). Compared with pro-
cedures classiﬁed as appropriate or uncertain,PCIs in AUC/2009
Procedural Appropriateness
p Value
ropriate
¼ 694)
Uncertain
(n ¼ 990)
Inappropriate
(n ¼ 298)
<0.001
2 (24.8) 145 (14.6) 238 (79.9)
7 (9.7) 283 (28.6) 27 (9.1)
(27.1) 529 (53.4) 33 (11.1)
(30.8) 25 (2.5) 0 (0)
(4.3) 8 (0.8) 0 (0)
3 (3.3) 0 (0) 0 (0)
<0.001
(2.7) 82 (8.3) 127 (42.6)
(32.9) 343 (34.6) 171 (57.4)
(22.5) 39 (3.9) 0 (0)
(10.1) 45 (4.5) 2 (0.7) <0.001
(15.7) 1 (0.1) 1 (0.3) <0.001
(41.8) 46 (4.6) 9 (3.0) <0.001
5 (2.2) 44 (4.4) 18 (6.0) 0.007
(45.5) 183 (18.5) 9 (3.0) <0.001
erior descending artery; 3VD ¼ 3-vessel disease; all other abbreviations as in Table 2.
TABLE 4 Most Frequent Clinical Scenarios for Nonacute PCIs Classiﬁed as Inappropriate and Uncertain by AUC/2009
AUC/2009
Scenario No.
Indication
Anatomy
Previous
CABG Symptoms
Cardiac Risk
(Noninvasive Tests)
Antianginal
Medication n (%)
Inappropriate PCIs 298
14a 1- or 2-vessel CAD, no proximal LAD involvement No Asymptomatic Intermediate None or minimal 146 (7.4)
12a 1- or 2-vessel CAD, no proximal LAD involvement No Asymptomatic Low None or minimal 60 (3.0)
12b 1- or 2-vessel CAD, no proximal LAD involvement No CCS class I or II Low None or minimal 57 (2.9)
56a $1 stenoses in non-CABG territory all bypass grafts patent Yes Asymptomatic Intermediate None or minimal 13 (0.7)
24a CTO of 1 major coronary artery without other coronary stenoses No Asymptomatic Intermediate None or minimal 12 (0.6)
Uncertain PCIs 990
18b 1- or 2-vessel CAD, no proximal LAD involvement No CCS class I or II Not available Not available 524 (26.4)
14b 1- or 2-vessel CAD, no proximal LAD involvement No CCS class I or II Intermediate None or minimal 174 (8.8)
30b 1-vessel CAD involving the proximal LAD No CCS class I or II Intermediate None or minimal 49 (2.5)
36a 2-vessel CAD involving the proximal LAD No Asymptomatic Intermediate None or minimal 42 (2.1)
16a 1- or 2-vessel CAD, no proximal LAD involvement No Asymptomatic High None or minimal 29 (1.5)
CAD ¼ coronary artery disease; all other abbreviations as in Tables 1 to 3.
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1005inappropriate PCIs were more likely to be performed
for patients who had no symptoms (appropriate,
24.8%; uncertain, 14.6%; inappropriate, 78.9%; p <
0.001), low-risk results from noninvasive testing
(appropriate, 2.7%; uncertain, 8.3%; inappropriate,
42.6%; p < 0.001), or chronic total occlusion
(appropriate, 2.2%; uncertain, 4.4%; inappropriate,
6.0%; p < 0.007) (Table 3). Overall, almost all of the
inappropriate PCIs were conﬁned to 5 scenarios, as
summarized in Table 4. Frequently encountered
scenarios included PCIs with suboptimal antianginal
medications or involvement of single or multiple
epicardial vessels other than the left main trunk or
PLAD.
Under AUC/2012, asymptomatic patients with 1- or
2-vessel CAD with no PLAD involvement and with-
out previous noninvasive testing (indication 18a in
AUC/2009, indication 20a in AUC/2012) were rated
as inappropriate (n ¼ 447). When these scenarios
were added, the percent of inappropriate PCIs
increased from 15.0% to 30.7% (Figure 2, Online
Table 1). Of these cases, as many as 120 (26.8%) were
evaluated using coronary CTA before the procedures,
and the results were positive in almost all the cases
(noninterpretable, 4 cases; negative, 1 case). The most
frequent clinical scenarios for nonacute PCIs classiﬁed
as inappropriate and uncertain by AUC/2012 are
summarized in Table 5.
ASSOCIATION BETWEEN TEMPORAL TRENDS OF
NONINVASIVE TESTING AND THE RATE OF
INAPPROPRIATE RATINGS. Figure 3 summarizes the
use of several noninvasive tests such as the stress
myocardial perfusion imaging and coronary CTA
and fractional ﬂow reserve (FFR). FFR is a pressure
wire–based ischemic evaluation during coronaryangiography. Figure 3 also demonstrates the temporal
trends of the proportion of inappropriate PCIs. Among
patients who underwent PCI, the proportion of pa-
tients evaluated with coronary CTA and FFR sub-
stantially increased (p for trend < 0.001), which
coincided with a decrease in use of the stress
myocardial perfusion imaging over the course of 5
years (p for trend < 0.001). Contemporaneously, the
proportion of inappropriate PCIs increased (p for
trend ¼ 0.003) in parallel with the increase in coro-
nary CTA use. Implementation of coronary CTA was
associated with the rating of inappropriate PCI (odds
ratio: 1.33; 95% conﬁdence interval: 1.03 to 1.70; p ¼
0.027). Further, the time variables were not inde-
pendently associated with the rating of inappropriate
PCI (Online Table 3).
Figure 4 presents the change in the proportion of
PCIs rated as inappropriate. Although the proportion
of inappropriate PCIs accounted for 30.7% of all the
elective procedures when the CT-based procedures
were classiﬁed as inappropriate, this proportion
decreased substantially (from 5.0% to 25.7%) when
the CT–based procedures were classiﬁed as appro-
priate. Although the proportion of inappropriate PCIs
tended to increase even when the CT-based pro-
cedures were classiﬁed as appropriate, the trend was
not statistically signiﬁcant (p for trend ¼ 0.09).DISCUSSION
In this contemporary, multicenter Japanese PCI reg-
istry, almost all acute PCIs were acceptable regardless
of the criteria applied. However, approximately one-
sixth of nonacute PCIs were rated as inappropriate
under the original criteria. Under the updated AUC/
TABLE 5 Most Frequent Clinical Scenarios for Nonacute PCIs Classiﬁed as Inappropriate and Uncertain by AUC/2012
AUC/2012
Scenario No.
Indication
n (%)Anatomy
Previous
CABG Symptoms Cardiac Risk
Antianginal
Medication
Inappropriate PCIs 745
20a 1- or 2-vessel CAD, no proximal LAD involvement No Asymptomatic Not performed Not available 447 (18.4)
16a 1- or 2-vessel CAD, no proximal LAD involvement No Asymptomatic Intermediate None or minimal 146 (6.0)
14a 1- or 2-vessel CAD, no proximal LAD involvement No Asymptomatic Low None or minimal 60 (2.5)
14b 1- or 2-vessel CAD, no proximal LAD involvement No CCS class I or II Low None or minimal 57 (2.3)
58a $1 stenoses in non-CABG territory, all bypass grafts patent Yes Asymptomatic Intermediate None or minimal 13 (0.6)
26a CTO of 1 major coronary artery without other coronary stenoses No Asymptomatic Intermediate None or minimal 12 (0.5)
Uncertain PCIs 990
20b 1- or 2-vessel CAD, no proximal LAD involvement No CCS class I or II Not available Not available 524 (21.6)
16b 1- or 2-vessel CAD, no proximal LAD involvement No CCS class I or II Intermediate None or minimal 174 (7.2)
32b 1-vessel CAD involving the proximal LAD No CCS class I or II Intermediate None or minimal 49 (2.0)
38a 2-vessel CAD involving the proximal LAD No Asymptomatic Intermediate None or minimal 42 (1.7)
18a 1- or 2-vessel CAD, no proximal LAD involvement No Asymptomatic High None or minimal 29 (1.2)
Abbreviations as in Tables 1 to 4.
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10062012, the rate of inappropriate PCIs increased to
nearly one-third because noninvasive stress testing
was not performed before a large number of elective
PCIs in Japan and was seemingly affected by the
increasing trend of coronary CTA.
Under the original criteria (AUC/2009), the pro-
portion of inappropriate procedures in our study was
almost within the range reported in previous studies.
Similar to our study, previous reports have shown
that almost all coronary revascularization procedures
performed in the acute setting were appropriate (4,6),
whereas ratings in nonacute settings varied widely,
from 11.6% to 17% depending on the study (4–6,15).
Additionally, the characteristics of the nonacute
procedures that we classiﬁed as inappropriate were
also concordant with those reported in previous
studies. Inappropriate PCIs were likely to be per-
formed in patients who were either asymptomatic or
mildly symptomatic (Canadian Cardiovascular Soci-
ety class I or II), were receiving suboptimal anti-
anginal medication, and had no PLAD coronary artery
stenosis. In our study, the proportion and indications
of inappropriate PCIs in Japan were similar to the
results of previous studies from North America, which
indicates that AUC/2009 may be useful for assessing
the appropriateness of PCIs internationally. The same
approach, including the education of physicians
regarding procedural appropriateness, is needed to
improve patient selection in nonacute settings
globally.
Between the 2009 and 2012 criteria, the pro-
portion of inappropriate procedures increased sub-
stantially from 15.0% to 30.7% in our registry,
whereas Hannan et al. (5) reported that the percentof inappropriate PCIs using New York State’s Cardiac
Surgery Reporting System and the Percutaneous
Coronary Interventions Reporting System would
increase from 14.3% with AUC/2009 to 23.2% when
AUC/2012 was applied. These increases were mainly
explained by the following scenario: asymptomatic
patients who did not undergo previous noninvasive
testing, presence of 1- or 2-vessel CAD, and no PLAD
involvement (indication 18a in AUC/2009, indication
20a in AUC/2012). In AUC/2009, this clinical scenario
was not rated because the panel members thought
that its likelihood was very low. However, these
cases would appear to be particularly inappropriate
for revascularization because there is no expectation
of survival beneﬁt and no possibility of improve-
ment in quality of life. Accordingly, in the revised
version AUC/2012, such cases were rated as inap-
propriate (10). Therefore, the greater increase in
inappropriate procedures in our registry compared
with the Hannan et al. (5) study is a reﬂection of the
unwillingness to perform previous noninvasive
stress testing in Japan.
Less frequent use of noninvasive stress testing may
be due to the advent of coronary CTA, which has
become recognized as a useful prognostic modality
(16). In fact, approximately one-third of the patients in
our registry who did not undergo noninvasive stress
testing underwent coronary CTA. Furthermore, the
proportion of inappropriate PCIs increased substan-
tially in parallel with the increase in the use of coro-
nary CTA. Because appropriateness criteria assign
much value to functional information in reﬂection
of a strong tilt toward physiological assessment of
ischemia in the United States, coronary CTA, which
FIGURE 3 Association Between Temporal Trends of Noninvasive Testing and
Frequency of Inappropriate Ratings
Gray area indicates the percentages of inappropriate procedures on the basis of original
appropriateness criteria (AUC/2009). CT ¼ computed tomography; FFR ¼ functional ﬂow
reserve; MPI ¼ myocardial perfusion imaging; PCI ¼ percutaneous coronary intervention.
FIGURE 4 Change in the Proportion of PCIs Rated as Inappropriate When CT-Based
Procedures Were Classiﬁed Not as Inappropriate but as Appropriate
Light brown indicates the trend of proportion of inappropriate PCIs when CT-based pro-
cedures were rated as inappropriate. Dark brown indicates the trend of proportion of
inappropriate PCIs when CT-based procedures were rated as appropriate. Abbreviations
as in Figure 3.
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1007only provides anatomic information, is not recognized
as one of the previous noninvasive tests under
these criteria. In recent studies, the excellent negative
predictive value and acceptable positive predictive
value with diagnostic use of coronary CTA have been
documented (17,18), and the analyses from the
CONFIRM registry have demonstrated the prognostic
value of coronary CTA. Those patients with non-
obstructive or obstructive CAD detected by coronary
CTA had an increased risk of long-term mortality
compared with those without (16), which might
indicate that the risk of adverse cardiovascular
events could be stratiﬁed by the extent of anatomic
lesions. Additionally, subanalysis of the COURAGE
trial demonstrated that the anatomic burden of
coronary disease, but not ischemic burden, pre-
dicted the risk of adverse cardiovascular events (19),
which emphasized the importance of anatomic as
well as ischemic assessment in patients with CAD.
Because such a potential impact of anatomic
assessment on adverse cardiovascular outcomes has
been demonstrated, we can argue that CT-based
procedures can be hypothetically graded as appro-
priate instead of inappropriate. In our analysis, the
proportion of inappropriate PCI decreased by 5%
when CT-based procedures were classiﬁed not as
inappropriate but as appropriate. This proportion of
inappropriate PCIs was similar to the ﬁndings of
earlier reports assessed using revised 2012 criteria
(5). This result might demonstrate that the appro-
priateness of PCIs in Japan was not properly
assessed according to the current criteria because
the recognition of CAD was totally different from
that in the United States. Further studies are needed
to evaluate the appropriateness of CT-guided PCIs,
which may suggest that a revision of AUC is needed.
Although revascularization for patients who show
no signs of functional ischemia is not the standard of
care under current guidelines (20), ischemic evalu-
ation is likely to be performed using FFR without a
previous stress test, on the basis of the results of
the FAME2 (Fractional Flow Reserve versus Angiog-
raphy for Multi-vessel Evaluation II) study (21).
Actually in our registry, the prevalence of PCIs using
FFR substantially increased, which coincided with
an increase in coronary CTA use. The number of
inappropriate PCIs showed an increasing trend even
when the CT-based procedures were excluded (or
considered appropriate). This may due to the in-
crease in the use of FFR. Because FFR enables the
evaluation of the signiﬁcance of CAD in the cardiac
catheterization laboratory, pre-procedural tests
might have been omitted in some of the patients.
Among the patients mapped to scenario 20a underAUC/2012, almost one-tenth underwent FFR. This
trend may indicate that methods for evaluating
ischemia have been changing. However, in AUC/
2009 or AUC/2012, ischemic evaluation by FFR is
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1008accepted only for 1- or 2-vessel CAD with borderline
stenosis of 50% to 60%. The use of FFR in coronary
artery stenosis >60% was not adjudicated, which
was also mentioned in the previous study (4). In
view of this, there is room for improvement in AUC/
2009 or AUC/2012 to permit a more precise evalua-
tion of appropriateness.
There are several reasons for the wide imple-
mentation of coronary CTA in Japan. First, high-
technology medical equipment including CT and
magnetic resonance imaging is widely available in
Japan; the number of CT scanners per million people
in Japan is estimated to be >7 times more than that in
the United States (22). Second, there is universal
health coverage in Japan, which makes it easier for
patients to access medical resources. In 1961, Japan
managed to extend social health insurance to the
entire population and achieved universal health
coverage (23). This health policy is equally applied to
all healthcare facilities, and the provision of equal
medical services is achieved across the entire nation.
Further studies focused speciﬁcally on coronary
CTA are needed to close this scientiﬁc gap in PCI
indications.
STUDY LIMITATIONS. For a thorough understand-
ing of our results, several limitations should be
acknowledged. First, not all hospitals that perform
PCI in Japan participate in our registry. Our registry,
however, is multicenter and includes a relatively
large number of procedures. We believe that this is
one of the representative Japanese databases on PCI
patients and that our results comprise the most
complete assessment of practice patterns throughout
Japan currently.
Second, the use of coronary CTA has become
more widespread in Japan compared with theUnited States. In 2010, the percent of PCI patients
evaluated with coronary CTA was >30% in Japan,
whereas it was only 2.7% in the United States (8).
Although there is a signiﬁcant gap in the use of
coronary CTA, the temporal trends of noninvasive
testing, in which previous anatomic assessment has
been increasing, are similar in both countries. This
means that similar trends regarding appropriateness
of PCIs will be highlighted in the near future in the
United States.
CONCLUSIONS
In a multicenter Japanese PCI registry, approximately
one-sixth of PCIs were rated as inappropriate under
the AUC/2009 in nonacute settings, and the rate of
inappropriate PCIs increased to approximately one-
third on the basis of the revised AUC/2012. The
signiﬁcant changes in the inappropriate PCI rating
between the 2009 and 2012 criteria may be due to the
technological evolution of cardiovascular imaging,
which continues to evolve in everyday cardiology
practice. Further effort is needed to reﬁne and correct
the growing disconnection between the AUC and
modern pre-PCI evaluation.
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